New York State Common Retirement Fund Viking Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 122,398 shares of VKTX stock, worth $5.18 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
122,398
Previous 59,063
107.23%
Holding current value
$5.18 Million
Previous $3.13 Million
147.49%
% of portfolio
0.01%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding VKTX
# of Institutions
473Shares Held
65.6MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$431 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$255 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$198 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$89.6 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$79.4 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.25B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...